|

FLOT (Fluorouracil+Leucovorin+Oxaliplatin+Docetaxel) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2/3: 1

Top Sponsors

  • The Netherlands Cancer Institute1

Indications

  • Resectable MMR-proficient Solid Tumors1
  • Resectable MMR-deficient Solid Tumors1
  • Cancer1

Other1 trial

Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.